Next, to reveal the differential expression of m6A molecules between the AML and control groups, we found that FTO was overexpressed in all cell types, YTHDF2 in erythrocytes, and IGF2BP2 in myeloid cells (Fig. 2e). The gene discussed is IGF2BP2; the disease is acute myeloid leukemia.